Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers

被引:47
作者
Kantzanou, M
Lucas, M
Barnes, E
Komatsu, H
Dusheiko, G
Ward, S
Harcourt, G
Klenerman, P
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England
[2] UCL, Royal Free Hosp, Dept Med, London NW3, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
HCV; immune escape; CD8+T lymphocyte; NS3; antigenic variation;
D O I
10.1016/S0165-2478(02)00224-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis C virus (HCV) has infected over 170 million people world wide, and in the majority sets up a chronic infection associated with hepatic inflammation. Ho it evades host immunity, particularly CD8+ T cells (CTL) is unclear, but two major factors are likely to operate. viral escape mutation and T cell exhaustion. We have investigated the role of CTL in control of infection during acute disease using Class I peptide tetramers. Although the immune response is quite diverse and numerous epitopes can be targeted, we observe that, especially during acute disease. one epitope (NS3 1073-81) is commonly recognised in HLA-A2 positive individuals. However, the levels of response to this epitope (and others) are very much lower if persistence is established. We examined in detail whether the cause of this low level of reactivity is due to mutation within the epitope. We find that, in fact this epitope is highly conserved during chronic infection, at a clonal level, between individuals, and over time. Thus, although variation within the epitope does occur. lack of reactivity in peripheral blood against this epitope in chronic disease, and loss of control of virus cannot be explained entirely by viral escape. Escape through Mutation probably does play an important role in persistence of HCV, but we also discuss other mechanisms which lead to attenuation of T cell responses which may be important in determining the outcome. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 41 条
[1]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[2]   Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) [J].
Bunce, M ;
ONeill, CM ;
Barnardo, MCNM ;
Krausa, P ;
Browning, MJ ;
Morris, PJ ;
Welsh, KI .
TISSUE ANTIGENS, 1995, 46 (05) :355-367
[3]   INDUCTION IN-VITRO OF A PRIMARY HUMAN ANTIVIRAL CYTOTOXIC T-CELL RESPONSE [J].
CERNY, A ;
FOWLER, P ;
BROTHERS, MA ;
HOUGHTON, M ;
SCHLICHT, HJ ;
CHISARI, FV .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) :627-630
[4]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF [J].
CERNY, A ;
MCHUTCHISON, JG ;
PASQUINELLI, C ;
BROWN, ME ;
BROTHERS, MA ;
GRABSCHEID, B ;
FOWLER, P ;
HOUGHTON, M ;
CHISARI, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :521-530
[5]   Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus [J].
Chang, KM ;
Rehermann, B ;
McHutchison, JG ;
Pasquinelli, C ;
Southwood, S ;
Sette, A ;
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2376-2385
[6]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[7]   The liver as a site of T-cell apoptosis: graveyard, or krilling field? [J].
Crispe, IN ;
Dao, T ;
Klugewitz, K ;
Mehal, WZ ;
Metz, DP .
IMMUNOLOGICAL REVIEWS, 2000, 174 :47-62
[8]   POSSIBLE MECHANISM INVOLVING T-LYMPHOCYTE RESPONSE TO NONSTRUCTURAL PROTEIN-3 IN VIRAL CLEARANCE IN ACUTE HEPATITIS-C VIRUS-INFECTION [J].
DIEPOLDER, HM ;
ZACHOVAL, R ;
HOFFMANN, RM ;
WIERENGA, EA ;
SANTANTONIO, T ;
JUNG, MC ;
EICHENLAUB, D ;
PAPE, GR .
LANCET, 1995, 346 (8981) :1006-1007
[9]   The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes [J].
Erickson, AL ;
Kimura, Y ;
Igarashi, S ;
Eichelberger, J ;
Houghton, M ;
Sidney, J ;
McKinney, D ;
Sette, A ;
Hughes, AL ;
Walker, CM .
IMMUNITY, 2001, 15 (06) :883-895
[10]   Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C [J].
Gerlach, JT ;
Diepolder, HM ;
Jung, MC ;
Gruener, NH ;
Schraut, WW ;
Zachoval, R ;
Hoffmann, R ;
Schirren, CA ;
Santantonio, T ;
Pape, GR .
GASTROENTEROLOGY, 1999, 117 (04) :933-941